by Chris Kamel | Feb 28, 2011
We’ve talked often about induced pluripotent stem cells (iPS cells) on this blog — the transformation of adult terminally differentiated cells into stem cells that can differentiate into various lineages — mostly in the context of discoveries in mice...
by Chris Kamel | Jan 24, 2011
Although tumours are typically thought of as a single entity, the cells that make up a tumour are genetically diverse. The traditional view of cancer progression — in which a tumour arises from a single cell after accumulated mutations — suggests that...
by Stem Cell Network | Jan 20, 2011
On January 20, 2011 Ernest (“Bun”) McCulloch passed away. Although Bun was known to the young generation of stem cell researchers only by reputation, for those of us who knew him “back then” he was an icon. “Back then” was the 60s and 70s when the group led by...
by Ubaka Ogbogu | Jan 13, 2011
A couple of significant updates to report on from the ethics and law arena: On December 22, 2010, the Supreme Court of Canada (SCC) released its long-awaited judgment in the Reference re: Assisted Human Reproduction Act case involving a constitutional challenge...
by Stem Cell Network | Jan 12, 2011
In an article in the Globe and Mail this past weekend, reporter Carolyn Abraham provided an interesting and under-reported glimpse into the cosmetics industry use of stem cells to market their products. She notes: “In science, ‘stem cell’ has been...
by Ubaka Ogbogu | Jan 4, 2011
In March 2009, in his remarks at the signing of an Executive Order to reverse the Bush-era stem cell research funding restrictions, President Obama directed John P. Holdren, Director of the Office of Science and Technology Policy, to “develop a strategy for restoring...
Comments